Skip to main content

The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders

This course was updated today. If you're about to take the exam, you may benefit from reviewing the exam questions listed below before starting on the actual exam.

About the Course

This intermediate and above level course is tailored for healthcare professionals who are seeking to enhance their expertise. Participants at the intermediate and above levels of knowledge will delve into comprehensive learning objectives designed to deepen their understanding and proficiency in this specialized field.
This course will include in-depth exploration of the relationship between pharmacotherapy and the risk of developing substance use disorders (SUDs) in adolescents and young adults with psychiatric disorders. Participants will critically analyze the impact of pharmacological treatments on substance use, misuse, and the development of SUDs in various psychiatric conditions, including attention-deficit/hyperactivity disorder (ADHD), major depressive disorder, and psychotic disorders. Emphasizing evidence-based practice, the course delves into the nuances of treatment initiation, duration, and adequacy, highlighting the importance of early intervention and prolonged treatment in reducing SUD risk.

This course is based on the reading-based online article, The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders created by Timothy E. Wilens, MD et al. in 2022.

Publication Date

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY 2022

Course Material Authors

Course Material Authors authored the material only, and were not involved in creating this CE course. They are identified here for your own evaluation of the relevancy of the material this course is based on.

Timothy E. Wilens, MD

Dr. Timothy Wilens is chief of the Division of Child and Adolescent Psychiatry and is co-director of the Center for Addiction Medicine at Massachusetts General Hospital. Dr. Wilens’ research interests include the relationship among attention deficit/hyperactivity disorder (ADHD), bipolar disorder, and substance use disorders; embedded health care models, and the pharmacotherapy of ADHD across the lifespan. He has published more than 300 peer-reviewed articles, concerning these and related topics. He has also coedited more than 80 book chapters, 4 books, and 300 abstracts and presentations for national and international scientific meetings.

Diana W. Woodward, PhD Student

Diana is a PhD student at the University of Southern California. She has more than 4 years of experience as a research assistant and has had multiple works published in peer reviewed journals.

Course Creator

Kathryn Held

Kathryn Held, Psy. D associate and CADC III, is an individual therapist at Visions adolescent treatment centers. With a decade of experience in the mental health field, Kathryn specializes in the treatment of anxiety disorders, OCD, and the OCD spectrum. Kathryn also has expertise in working with LGBTQ+ adolescents while navigating complex family systems. Her current research projects include adolescent suicide and the use of OCD art interventions in anxiety and OCD treatment. She is trained in CBT, ACT and Exposure and Response Prevention. Her empathetic and artistic approach helps support, educate, and instill agency in her clients. Prior to joining the Visions team, Kathryn worked in various treatment settings including detox, sober living, and as the Program Director of a dual diagnosis outpatient treatment center.

Recommended For

Counselors, marriage and family therapists, psychologists and social workers. This course is appropriate for intermediate and above levels of knowledge.

Course Objectives:

After taking this course, you should be able to:

  1. Analyze the findings on pharmacological treatments of psychiatric disorders in adolescents and young adults, specifically focusing on their impact on substance use, and the development of substance use disorders (SUDs).
  2. Describe the implications of earlier-onset and longer-duration pharmacotherapy in reducing the risk of developing SUDs in youth with psychiatric disorders, considering the nuances of treatment initiation, duration, and adequacy.
  3. Summarize current research findings to inform clinical decision-making processes for counselors, marriage and family therapists, psychologists, and social workers working with youth populations, regarding the integration of pharmacotherapy into comprehensive treatment plans aimed at addressing both psychiatric symptoms and mitigating the risk of SUD development.

Availability

This course is available starting Jun 13th, 2024 and expires Dec 30th, 2038

Disclosure to Learners

Disclosure of Relevant Financial Relationships

Exam Questions

All exam questions for the course are visible on this page for members of Addiction Counselor CE.

Membership is free, and you can register today! You'll only pay when you're ready to purchase a course, or if you take advantage of the Unlimited Package.

If you're already a member, please sign in to see the exam questions for this and all other courses.

Discuss this course

You can share your thoughts about this course after you pass the exam.

Sign In or Register to get started.

FAQs

  • Is this course approved for my continuing education requirements?

  • Do you have accommodations for my disability (ADA)?

  • How do I enroll in this course?

  • What do I have to do to complete the course?

  • How do I access the materials?

  • How do I get my certificate?

  • Can I contact you for more help?

Course Number 103499
1 CE credit hour
Sign in for credit hours relevant to your credentials.

  • Reading-Based Online
Exam Fee $5.97
There's no exam fee with an Unlimited CE membership! Read More

No Cost Materials

195 members have taken this course

Try a free CE course.

Get started by trying a free course of your choice. No payment info required!

Sign Up Free

View all free trial courses

Happy therapist using Addiction Counselor CE